Skip to main content
logo
BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
10.46
+1.42 (15.71%)
Aug 3, 2026, 12:16 PM EDT - Market open

BioAge Labs Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
10.329---
Revenue Growth
610.96%----
Gross Profit
10.329---
Operating Income
-101.71-92.78-78.19-48.4-39.97
Net Income
-89.93-80.61-71.11-63.85-39.72
Earnings Per Share
-2.40-2.24-6.63-38.1723.76
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
383.19281.1354.3524.9627.64
Total Debt
4.035.568.735.072.47
Net Cash (Debt)
379.16275.54345.65-10.1125.18
Net Cash Growth
22.23%-20.28%---
Net Cash Per Share
10.097.6732.22-6.0415.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-88.31-81.63-51.52-37.36-36.18
Capital Expenditures
-0.32-0.72-0.37-0.17-0.1
Free Cash Flow
-88.63-82.35-51.89-37.53-36.28
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
100.00%100.00%---
Operating Margin
-985.93%-1031.46%---
Pretax Margin
-871.75%-896.11%---
Profit Margin
-871.75%-896.11%---
FCF Margin
-859.14%-915.46%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
45.0754.99---